Contact
searchSearch
HMP Global

Medication Safety News

News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network
News
Antifibrinolytic Drug Recalled
06/23/2023
Jolynn Tumolo
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two...
06/23/2023
Pharmacy Learning Network
News
Injection Recalled After Manufacturer Halts Quality Program
06/16/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been...
06/16/2023
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use